Quinazolinones As Parp14 Inhibitors

Patent No. EP4212515 (titled "Quinazolinones As Parp14 Inhibitors") was filed by Abbvie Biotechnology on Dec 20, 2018. The application was issued on Jul 19, 2023.

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4212515

ABBVIE BIOTECHNOLOGY
Application Number
EP22212226A
Filing Date
Dec 20, 2018
Status
Intended To Grant
Apr 29, 2025
Publication Date
Jul 19, 2023